Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/96975
標題: 肥培管理對丹參(Salvia miltiorrhiza)活性成分之影響
Effects of Fertilization on the Active Components of Salvia miltiorrhiza
作者: 王淑愼
Shu-Shen Wang
關鍵字: 施肥管理
丹參
丹酚酸B
丹參酮I
丹參酮IIA
fertilization
salvia miltiorrhiza
salvianolic acid B
tanshinone I
tanshinone IIA
引用: 中尾萬三、福島忠勝。1934。漢藥丹參成份研究藥學雜誌 54(9): 844。 曲桂武、解飛霞、岳喜典、劉影、李桂生。2005。丹參酚酸B和丹參酮IIA在丹參根中的分布中藥研究與信息7:1-3。 李鎮孙。2009。增加丹參癒合組織中丹參酮含量以及丹參酮I抑制非小細胞肺癌作用之研究中興大學農藝學系研究所博士論文,臺中,臺灣。 林珠鳳。2006。建立丹參轉殖毛狀根系統及其二次代謝物生產之研究中興大學農藝學系研究所碩士論文,臺中,臺灣。 高瑞隆、余志儒、陳琦玲、李豔琪、謝廷芳、胡敏夫。2007。肥培管理對薑黃產量及薑黃素含量之影響台灣農業研究(J. Taiwan Agric. Res.) 56(3): 165-175。 張同吳。2009。東部地區中草藥產業發展之現況與展望行政院農業委員會花蓮區農業改良場國際中草藥產業發展研討會專刊89-105。 張同吳。2011。臺灣丹參優良農業操作體系之建立行政院農業委員會花蓮區農業改良場臺灣丹參產業發展研討會專刊 p.51-63 張同吳。2013。不同生育期及收穫期對丹參產量與有效成分含量之影響花蓮區農業改良場研究彙報(Bull. Hualien DARES)31:43-51。 陳仁炫 2004 栽培介質與植體營養診斷技術植物重要防疫檢疫病害診斷鑑定技術研習會專刊(三) 157-174。 陳世雄。2004。中草藥有機栽培原理行政院農業委員會花蓮區農業改良場生產者知識庫研討會論文 p.9-12。 陳威臣、曹進義、夏奇鈮。2007。丹參組織培養苗馴化處理及其植株丹參酮含量分析 台灣農業研究(J.TaiwanAgric.Res.)56(1):21-30。 陳春玲。2007。丹參生理活性物質之純化製備與分析鑑定 朝陽科技大學生物技術研究所碩士論文,臺中,臺灣。 陳芷葳。2013。丹參化學成分與炮制的選擇(上)藥師週刊電子報 中藥學堂1813:。 郭朝禎、王美琪、曾志正。2011。活血化瘀的丹參科學發展460:54-59。 彭德昌。2004。栽培介質分析與植體診斷在作物合理化施肥之應用花蓮區農業專訊50: 35-40。 52 曾英傑、林玨羽、張同吳、宣大帄、黃鵬。2011。丹參萃取物之藥理與生理活性之研究行政院農業委員會,丹參的藥理研究87-92。 湛月娥。2007。丹酚酸B 藥理作用的研究進展華南國防醫學雜誌 21(2): 37-41。 黃良得。2010。國產丹參的發展現況及潛力臺大農業推廣通訊雙月刊83:。 黃頌哲 2011 有機質肥料不同施用量對丹參生長、生理營養與活性成分累積之影響 國立台灣大學生物暨農業學院農業化學系碩士論文 臺北,臺灣。 無名氏丹参的主要化學成分、藥理作用和功效。 鄞偈帆、高士傑、阮雪芬。2015。丹參的效用—從心血管疾病的治療到抗癌 科技報導403:。 劉新裕。2007。保健藥用植物之GAP栽培管理農業生技產業季刊28:30-31。 劉黎兒。2015。你喝的是中藥還是農藥?日本自己種藥材民報。 劉翠玲。2011。代謝症候群保健食品市場概況分析農業生技季刊 27:1-3。 衛生福利部國家中醫藥研究所圖書館編輯。2010。活血化瘀中藥──丹參的研究回顧與新知。http://www.nricm.edu.tw/files/14-1000-886,r11-1.php?Lang=zh-tw 賴柏鈞。2007。選殖關於丹參中將酪胺酸轉換成丹參素相關的三個酵素之cDNA中興大學生物科技學研究所碩士論文,臺中,臺灣。 隴南日報。2014。中草藥種植的施肥方法。 蘇進成。2013。以動物實驗評估丹參及丹參酮的作用 中醫藥司 中醫藥年報29(7):243-244。 Caldas, E.D., and L.L. Machado. 2004. Cadmium, mercury and in medicinal herbs in Brazil. Food Chem. Toxicol. 42: 599-603. Chang, P. N., J. C. Mao, S. H. Huang, L. Ning, Z. J. Wang, T. On, W. Duan& Y. Z.Zhu. 2006. Analysis of cardioprotective effects using purified Salvia miltiorrhiza extract on isolated rat hearts. J Pharmacol Sci. 101: 245-9. Chen, T. H., Y. T. Hsu, C. H. Chen, S. H. Kao & H. M. Lee. 2007a. Tanshinone IIA from Salvia miltiorrhiza induces heme oxygenase-1 53 expression and inhibits lipopolysaccharide-induced nitric oxide expression in RAW 264.7 cells. Mitochondrion. 7: 101-5. Chen, X., Z. W. Zhou, C. C. Xue, X. X. Li & S. F. Zhou. 2007b. Role of P-glycoprotein in restricting the brain penetration of tanshinone IIA, a majoractive constituent from the root of Salvia miltiorrhiza Bunge, across the blood-brain barrier. Xenobiotica.37: 635-78. Gong, Y., Y. Li, Y. Lu, L. Li, H. Abdolmaleky, G. L. Blackburn & J. R. Zhou. 2010. Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostatecancer cells in vitro and in mice. Int. J. Cancer. Gu, M., Z. Wang, Su and F. Ouyang. 2007. One step-separation and purification of 3,4-dihydroxyphenylacetic acid, salvianolic acid B and protocatechualdehyde from Salvia miltiorrhiza Bunge by high speed counter –current chromatography. J. Chromatogr. A. 1140: 107-111. Hu, Z. B., D. Liu, and A. W. Alfermann. 1999. Genetic transformation of Salvia miltiorrhiza. p.249-260 in: Biotechnology in Agriculture and Forestry 45, Transgenetic Medical Plant (Bajaj, Y. P. S. ed) . Springer-Verlag, Berlin. Huang, K.J., H. Wang, W. Z. Xie & H. S. Zhang. 2007. Investigation of the effectof tanshinone IIA on nitric oxide production in human vascular endothelial cells by fluorescence imaging. Spectrochim Acta A Mol Biomol Spectrosc. 68: 1180-1186. Jang, S. I., H. J. Kim, Y. J. Kim, S. I. Jeong & Y. O. You. 2006. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possibleinvolvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur. JPharmacol.542: 1-7. Jang, S. I., S. I. Jeong, K. J. Kim, H. J. Kim, H. H. Yu, R. Park, H. M. Kim & Y. O.You. 2003. Tanshinone IIA from Salvia miltiorrhiza inhibits inducible nitricoxide synthase expression and production of TNF-alpha, IL-1beta and IL-6 in activated RAW 264.7 cells. Planta Med. 69: 1057-1059. Lee, C. Y., H. F. Sher, H. W. Chen, C. C. Liu, C. H. Chen, C. S. Lin, P. C. Yang, H.S. Tsay & J. J. Chen. 2008. Anticancer effects of tanshinone I in 54 humannon-small cell lung cancer. Mol. Cancer Ther.7: 3527-3538. Lee, S. Y., D. Y. Choi & E. R. Woo. 2005. Inhibition of osteoclast differentiation by tanshinones from the root of Salvia miltiorrhiza bunge. Arch. Pharm. Res. 28: 909-913. Park, S. ,J. S. Song, D. K. Lee, and C. H. Yang. 1999. Suppression of AP-1 activity by tanshinone and cancer cell growth inhibition. Bull. Korean Chem. Soc. 20: 925-928. Ren, Z. H., Y. H. Tong, W. Xu, J. Ma & Y. Chen. 2010. Tanshinone IIA attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1expression. Phytomedicine.17: 212-218. Saper, R. B., S. N. Kales, J. Paquin, M. J. Burns, D. M. Eisenberg, R. B. Davis, and R. S. Phillips. 2004. Heavy Metal Content of Ayurvedic Herbal Medicine Products. Journal American Medical Association(JAMA)292: 2868-2873. Tang, F., X. Wu, T. Wang, P. Wang, R. Li, H. Zhang, J. Gao, S. Chen, L. Bao, H.Huang & P. Liu. 2007. Tanshinone IIA attenuates atherosclerotic calcificationin rat model by inhibition of oxidative stress. Vascul. Pharmacol.46: 427-438. Tang, Z., Y. Tang & L. Fu. 2003a. Growth inhibition and apoptosis induction inhuman hepatoma cells by tanshinone IIA. J Huazhong Univ Sci Technolog Med Sci.23: 166-168, 172. Tang, Z. Z., Y. Tang & L. B. Fu. 2003b. [Effect of tanshinone IIA on the growth behavior of human hepatoma cell line BEL-7402 in vitro and its mechanism]. Di Yi Jun Yi Da Xue Xue Bao. 23: 595-597, 601. Wang, X., Y. Wei, S. Yuan, G. Liu, Y. Lu, J. Zhang & W. Wang. 2005. Potentialanticancer activity of tanshinone IIA against human breast cancer. Int. J. Cancer.116: 799-807. Wang, X., S. Yuan, R. Huang & Y. Song. 1996a. [An observation of the effect oftanshinone on cancer cell proliferation by Brdu and PCNA labeling]. Hua Xi YiKe Da Xue Xue Bao. 27: 388-391. Wu,Y.J., C.Y.Hong, S.J.Lin, and M.S.Shiao. 1998. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed 55 rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Arterioscler. Thromb. Vasc. Biol. 18: 481-486. Yang, L. J., C. J. Jeng, H. N. Kung, C. C. Chang, A. G. Wang, G. Y. Chau, M. J.Don & Y. P. Chau. 2005. Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells. J. Biomed Sci. 12: 347-361. Yuan, S., Y. Wang, X.Chen, Y.Song & Y.Yang. 2002. [A study on apoptosis of nasopharyngeal carcinoma cell line induced by Tanshinone IIA and itsmolecular mechanism]. Hua Xi Yi Ke Da Xue Xue Bao.33: 84-86, 90. Yuan, S. L., Y. Q. Wei, X. J. Wang, F. Xiao, S. F. Li & J. Zhang. 2004. Growth inhibition and apoptosis induction of tanshinone IIA on human hepatocellular carcinoma cells. World J. Gastroenterol.10: 2024-2028. Zhang, H. S. & S. Q. Wang. 2007. Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells. Biochem Pharmacol.73: 1358-1366. Zhao, B. L., W. Jiang, Y. Zhao, J. W. Hou & W. J. Xin. 1996. Scavenging effectsof Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem. Mol. BiolInt. 38: 1171-1182. Zhong, Z. H., W. G. Chen, Y. H. Liu, Q. X. Li & Y. Qiu. 2007. [Inhibition of cellgrowth and induction of apoptosis in human hepatoma cell line HepG2 by tanshione IIA]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 32: 99-103. Zhou, L., Z. Zuo & M. S. Chow. 2005. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J, Clin. Pharmacol. 45: 1345-1359.
摘要: 丹參(Salvia miltiorrhiza)是唇形科鼠尾草屬(Salvia)多年生草本植物, 為中藥複方中常見的藥材。丹參的活性成分主要分為兩大類:水溶性和脂 溶性化合物,水溶性化合物常見的有丹參酚酸B,脂溶性化合物中為丹參 酮I、丹參酮IIA 與隱丹參酮。本研究目的為探討氮磷鉀肥施用比率對對 丹參活性成分的影響。本研究有N0P0K0、N100P40K100、N100P40K150、 N100P40K200、N150P60K100、N150P60K150、及N150P60K200 等七個 處理,盆栽置於網室中,5 個逢機完全區集,每區集每處理有兩盆。處理 的數字表示灌肥養液濃度為0、40、100、150、或200 mg/L,盆栽種植 260 天採收分析植體及栽培介質養分濃度及丹蔘主要活性成分濃度。研究 結果顯示,丹參活性成分丹參酚酸B 在N150P60K100 施肥處理濃度最高, 其值為57.46g/kg,次之為施肥處理N100P40K100 時,其值為56.21g/kg; 而N100P40K150 施肥處理時,丹參酮類及雙氫丹參酮的活性成分達到最高。 研究發現,適量的施用鉀肥(K100),萃取的丹參活性成分丹參酚酸B、 丹參酮類濃度高。高量的氮、磷、鉀施肥處理對丹參活性成分有降低的趨 勢,但是由於產量提高其有效成分的總收穫量較高。丹參栽種,在氮、磷、 鉀、鎂施肥的比例處理,建議用5-2-5-0.5 或7.5-3-5-0.5 的比例,能得到 高濃度的丹參酚酸B 和丹參酮類活性成分。
Salvia miltiorrhiza is a perennial herb of Salvia,whichis a very commonly traditional Chinese medicine. Salvia miltiorrhiza has many active ingredients, salvianolic acid B is water soluble, and tanshinone I, tanshinone IIA and cryptotanshinone are lipid-sluble. The purpose of this study was to invest the effect of NPK fertilizer ratios on the concentration of active constituents of salvia miltiorrhiza. There are seven treatments N0P0K0, N100P40K100 , N100P40K150 , N100P40K200 , N150P60 K100 , N150P60K150, and N150P60K200, the value of each treatment represent the concentration of nutrient prepared for fertilization which are 0, 40, 60, 100, 150, and 200 mg/L. The pots were set in randomly complete plot design with 5 replications, each treatment had two pots in each plot, and carried out under a net house. Potted plants were harvested after planted for 260 days, then the growth media and plant tissues were prepared for properties, nutrients, and active compounds analysis. Results showed that salvianolic acid B concentration of treatment N150P60K100 was the highest with concentration at 57.46 g / kg, followed by treatment N100P40K100, at 56.21 g / kg. The N100P40K150 treatment had highest concentrations of tanshinones and dihydrotanshinone.This study found that the treatments with K100 had higher active ingredient salvianolic acid B, and tanshinones concentrations. The higher rate of nitrogen, phosphorus and potassium fertilizers had a declining effect on the concentration of active components of salvia miltiorrhiza, but had higher total contents with their higher dry weight harvest. Salvia miltiorrhiza planting in the ratio of nitrogen, phosphorus, potassium and magnesium fertilizer treatment at 5-2-5-0.5 or 7.5-3-5-0.5 ratio, can have reasonable high concentrations of salvianolic acid B and tanshinone.
URI: http://hdl.handle.net/11455/96975
文章公開時間: 2021-02-08
Appears in Collections:農業企業經營管理碩士在職專班

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.